OVI-117

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug NameOVI-117
Drug Alias NameL-nucleoside conjugate (OVI-117)Derivative of FduMP/5-FU (OVI-117)L-117OVI-117
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionThymidylate synthase inhibitors
TargetsThymidylate synthase
Therapy Area/IndicationsColorectal Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesLipitek InternationalDupont Pharma
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDupont PharmaOncovista Innovative TherapiesLipitek International
Active IndicationsN/A
Inactive IndicationsColorectal Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A